Regorafenib inhibits tumor progression through suppression of ERK/NF-κB activation in hepatocellular carcinoma bearing mice

Regorafenib has been demonstrated in our previous study to trigger apoptosis through suppression of extracellular signal-regulated kinase (ERK)/nuclear factor-κB (NF-κB) activation in hepatocellular carcinoma (HCC) SK-Hep1 cells in vitro. However, the effect of regorafenib on NF-κB-modulated tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Mao-Chi, Wang, Mei-Hui, Tsai, Jai-Jen, Kuo, Yu-Cheng, Liu, Yu-Chang, Hsu, Fei-Ting, Wang, Hsin-Ell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938429/
https://www.ncbi.nlm.nih.gov/pubmed/29535278
http://dx.doi.org/10.1042/BSR20171264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938429/
https://www.ncbi.nlm.nih.gov/pubmed/29535278
http://dx.doi.org/10.1042/BSR20171264

Ejemplares similares